Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency. 2006

Richard Kirsch, and Vivian Clarkson, and Robert C Verdonk, and Adrian D Marais, and Enid G Shephard, and Bernard Ryffel, and Pauline de la M Hall
Department of Anatomical Pathology, Cape Heart Center and Medical Research Council, Cape Town, South Africa. rich@chempath.uct.ac.za

OBJECTIVE Intestinal endotoxin (lipopolysaccharide) is thought to contribute to liver injury in both alcoholic and nonalcoholic steatohepatitis (NASH). Tumor necrosis factor alpha (TNFalpha) is an important mediator of this process and is considered central to the inflammatory response in NASH. This study aimed to investigate the effects of lipopolysaccharide on liver injury in the methionine choline deficient (MCD) nutritional model of NASH, and to determine if TNFalpha is required for the development of steatohepatitis in this model. METHODS Male C57/BL6 mice received a MCD diet for 4 weeks, whilst a control group received an identical diet supplemented with 0.2% choline bitartrate and 0.3% methionine. At 4 weeks, mice received either an intraperitoneal injection of lipopolysaccharide (0.5 microg/g body mass) or sterile saline, and were killed 24 h thereafter. In a separate study, TNFalpha knockout and wild type C57BL/6 mice received either MCD or control diets for 4 weeks. Serum transaminase levels, liver histology (steatosis, inflammation and apoptosis), hepatic triglyceride concentration and hepatic lipid peroxidation products (conjugated dienes, lipid hydroperoxides and thiobarbituric reactive substances, free and total) were evaluated. RESULTS Intraperitoneal administration of lipopolysaccharide augmented serum alanine aminotransferase (ALT) levels (P<0.02), hepatic inflammation (P<0.025), apoptosis (P<0.01) and free thiobarbituric acid reactive substances (P<0.025) in MCD mice. TNFalpha knockout mice fed the MCD diet developed steatohepatitis with histological and biochemical changes similar to those seen in wild type counterparts. CONCLUSIONS Lipopolysaccharide augments liver injury in MCD mice, and TNFalpha is not required for the development of steatohepatitis in MCD mice.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008715 Methionine A sulfur-containing essential L-amino acid that is important in many body functions. L-Methionine,Liquimeth,Methionine, L-Isomer,Pedameth,L-Isomer Methionine,Methionine, L Isomer
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002796 Choline Deficiency A condition produced by a deficiency of CHOLINE in animals. Choline is known as a lipotropic agent because it has been shown to promote the transport of excess fat from the liver under certain conditions in laboratory animals. Combined deficiency of choline (included in the B vitamin complex) and all other methyl group donors causes liver cirrhosis in some animals. Unlike compounds normally considered as vitamins, choline does not serve as a cofactor in enzymatic reactions. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984) Deficiency, Choline,Choline Deficiencies,Deficiencies, Choline
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005234 Fatty Liver Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS. Liver Steatosis,Steatohepatitis,Steatosis of Liver,Visceral Steatosis,Liver Steatoses,Liver, Fatty,Steatohepatitides,Steatoses, Liver,Steatoses, Visceral,Steatosis, Liver,Steatosis, Visceral,Visceral Steatoses
D000410 Alanine Transaminase An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2. Alanine Aminotransferase,Glutamic-Pyruvic Transaminase,SGPT,Alanine-2-Oxoglutarate Aminotransferase,Glutamic-Alanine Transaminase,Alanine 2 Oxoglutarate Aminotransferase,Aminotransferase, Alanine,Aminotransferase, Alanine-2-Oxoglutarate,Glutamic Alanine Transaminase,Glutamic Pyruvic Transaminase,Transaminase, Alanine,Transaminase, Glutamic-Alanine,Transaminase, Glutamic-Pyruvic

Related Publications

Richard Kirsch, and Vivian Clarkson, and Robert C Verdonk, and Adrian D Marais, and Enid G Shephard, and Bernard Ryffel, and Pauline de la M Hall
June 1990, Inflammation,
Richard Kirsch, and Vivian Clarkson, and Robert C Verdonk, and Adrian D Marais, and Enid G Shephard, and Bernard Ryffel, and Pauline de la M Hall
February 1991, Circulatory shock,
Richard Kirsch, and Vivian Clarkson, and Robert C Verdonk, and Adrian D Marais, and Enid G Shephard, and Bernard Ryffel, and Pauline de la M Hall
September 1997, Alcoholism, clinical and experimental research,
Richard Kirsch, and Vivian Clarkson, and Robert C Verdonk, and Adrian D Marais, and Enid G Shephard, and Bernard Ryffel, and Pauline de la M Hall
February 1993, Infection and immunity,
Richard Kirsch, and Vivian Clarkson, and Robert C Verdonk, and Adrian D Marais, and Enid G Shephard, and Bernard Ryffel, and Pauline de la M Hall
January 1999, Natural toxins,
Richard Kirsch, and Vivian Clarkson, and Robert C Verdonk, and Adrian D Marais, and Enid G Shephard, and Bernard Ryffel, and Pauline de la M Hall
March 2011, Investigative ophthalmology & visual science,
Richard Kirsch, and Vivian Clarkson, and Robert C Verdonk, and Adrian D Marais, and Enid G Shephard, and Bernard Ryffel, and Pauline de la M Hall
August 2006, FEMS immunology and medical microbiology,
Richard Kirsch, and Vivian Clarkson, and Robert C Verdonk, and Adrian D Marais, and Enid G Shephard, and Bernard Ryffel, and Pauline de la M Hall
September 2007, The Journal of biological chemistry,
Richard Kirsch, and Vivian Clarkson, and Robert C Verdonk, and Adrian D Marais, and Enid G Shephard, and Bernard Ryffel, and Pauline de la M Hall
January 1990, Proceedings of the Western Pharmacology Society,
Richard Kirsch, and Vivian Clarkson, and Robert C Verdonk, and Adrian D Marais, and Enid G Shephard, and Bernard Ryffel, and Pauline de la M Hall
August 1995, The American journal of physiology,
Copied contents to your clipboard!